Myriapod® is the advanced NGS-based diagnostic solution for detecting clinically relevant genomic variants in precision oncology.
Adapting to your lab, advancing care for your patients.
Built for today’s clinical challenges, Myriapod® NGS portfolio offers the flexibility to meet diverse needs, from targeted tests to comprehensive insights. Scalable and precise, it helps bring personalized answers to every cancer patient, at every step, everywhere.
Myriapod® NGS Data Analysis- On-Premise Bioinformatics for Clinical Genomics
The Myriapod NGS Data Analysis suite is a robust, on-premise bioinformatics solution combining a high-performance workstation with proprietary software for streamlined
NGS data processing, even in an environment without bioinformatics expertise.
Smart Variant Analysis: SNVs, InDels, CNV, Fusions, MSI, HRD & HRR automatically identified – no bioinformatics expertise needed.
Total Data Protection: 100% local processing. No cloud. No external servers. No compromises.
QC You Can Trust: Automatic run and sample validation, every time.
Built-In Intelligence: Variants classified using trusted genomic databases.
